Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Draegerwerk 9M net sales rise, EBIT jumps on one-off gains

By Reuters News


Overview

  • Germany medical and safety tech firm's 9M net sales rose 4.7% to EUR 2.45 bln

  • EBIT up nearly 50%, aided by one-off customs refunds

  • Company maintains 2026 forecast for net sales growth of 2-6% and EBIT margin of 6-8%


Outlook

  • Drägerwerk maintains 2026 forecast for net sales growth of 2.0-6.0% (net of currency effects)

  • Company expects 2026 EBIT margin of 6.0-8.0%


Result Drivers

  • CUSTOMS REFUNDS - Co said one-off effects from U.S. customs refunds contributed EUR 27.9 mln to EBIT, including EUR 20.1 mln in Q3

  • SAFETY DIVISION GROWTH - Safety division order intake increased 13.1% (net of currency effects), with all regions and product areas contributing

  • GERMANY DEMAND - Germany was the largest growth driver, with order intake up 15% in 9M and 59% in Q3, boosted by defense orders


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

9M Sales

EUR 2.45 bln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

  • Wall Street's median 12-month price target for Draegerwerk AG & Co KGaA is €101.50, about 31.8% above its October 28 closing price of €77.00

  • The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago


Reuters Recommended Reads

  • Oct 28 - Boston Scientific Q3 revenue beats estimates despite cybersecurity disruption

  • Oct 28 - GE Healthcare Q3 profit beats estimates on advanced imaging segment

  • Oct 27 - Sweden's Alfa Laval Q3 sales rise on order intake


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.